Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03051685 · ClinicalTrials.gov registry record · Phase 1
Bioavailability of DFN-15 at 3 Different Doses vs. Comparator and to Determine Dose-proportionality of DFN-15 in Fasting Healthy Adults
A Phase 1 study, sponsored by Dr. Reddy's Laboratories Limited.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT03051685 is a Phase 1 study that has completed, run by Dr. Reddy's Laboratories Limited. The registered enrollment target is 16 participants.
The verdict
NCT03051685, a Phase 1 study, has completed, sponsored by Dr. Reddy's Laboratories Limited.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
Crossover study to compare the BA of DFN-15 at 3 different doses versus the comparator to determine dose-proportionality of DFN-15 in healthy volunteers under fasting conditions
Interventions
- DRUG Active Comparator
- DRUG DFN-15 Dose 1
- DRUG DFN-15 Dose 2
- DRUG DFN-15 Dose 3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2015-07-20 |
| Est. Completion | 2015-11-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03051685
The ClinicalTrials.gov registry entry for NCT03051685 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dr. Reddy's Laboratories Limited, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Active Comparator is the first listed.
NCT03051685 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03051685 about?
NCT03051685 is a clinical study titled "Bioavailability of DFN-15 at 3 Different Doses vs. Comparator and to Determine Dose-proportionality of DFN-15 in Fasting Healthy Adults". Crossover study to compare the BA of DFN-15 at 3 different doses versus the comparator to determine dose-proportionality of DFN-15 in healthy volunteers under fasting conditions
What is the current status of trial NCT03051685?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2015-07-20. Estimated completion is 2015-11-10.
What interventions are being tested in trial NCT03051685?
The interventions under investigation include: Active Comparator (DRUG), DFN-15 Dose 1 (DRUG), DFN-15 Dose 2 (DRUG), DFN-15 Dose 3 (DRUG).
Who is sponsoring clinical trial NCT03051685?
This trial is sponsored by Dr. Reddy's Laboratories Limited, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.